Holen Sie sich die Stockscreener-App
6.105
1.95%
0.105
Schlusskurs vom Vortag:
$6.00
Offen:
$6.08
24-Stunden-Volumen:
140.22K
Relative Volume:
0.16
Marktkapitalisierung:
$532.75M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-95.90M
KGV:
-4.625
EPS:
-1.32
Netto-Cashflow:
$-79.09M
1W Leistung:
+16.07%
1M Leistung:
+66.22%
6M Leistung:
+31.83%
1J Leistung:
-31.81%
1-Tages-Spanne:
$5.99
$6.18
1-Wochen-Bereich:
$5.24
$6.18
52-Wochen-Spanne:
$1.865
$11.40
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
Firmenname
Terns Pharmaceuticals Inc
Sektor
Branche
Telefon
650-525-5535 EXT.101
Adresse
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Vergleichen Sie TERN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
6.10 | 441.06M | 0 | -95.90M | -79.09M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.11 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.63 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.71 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
574.62 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.37 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-28 | Eingeleitet | William Blair | Mkt Perform |
| 2024-10-31 | Eingeleitet | Oppenheimer | Outperform |
| 2023-06-22 | Eingeleitet | Mizuho | Buy |
| 2023-06-07 | Eingeleitet | Jefferies | Buy |
| 2023-05-31 | Eingeleitet | ROTH MKM | Buy |
| 2023-05-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-02-14 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-02-07 | Eingeleitet | UBS | Buy |
| 2022-09-12 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-09-14 | Fortgesetzt | Goldman | Buy |
| 2021-03-02 | Eingeleitet | Cowen | Outperform |
| 2021-03-02 | Eingeleitet | Goldman | Buy |
| 2021-03-02 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Terns Pharmaceuticals Inc Aktie (TERN) Neueste Nachrichten
What drives Terns Pharmaceuticals Inc. stock priceFree Market Volatility Navigation Tips - Autocar Professional
What analysts say about Terns Pharmaceuticals Inc. stockLightning-fast growth - Autocar Professional
Is Terns Pharmaceuticals Inc. a good long term investmentFree Wealth Management Insights - jammulinksnews.com
Why Terns Pharmaceuticals Inc. stock attracts strong analyst attentionDaily Price Surge List - Newser
Terns Pharmaceuticals Inc. Stock Analysis and ForecastConsistently high yield - printweek.in
What makes Terns Pharmaceuticals Inc. stock price move sharplyWeekly Big Movers - beatles.ru
How Terns Pharmaceuticals Inc. stock performs during market volatilityPro Trader Stock Focus - Newser
Terns Pharmaceuticals: A Catalyst-Driven Contrarian Play in Q4 2025 - AInvest
Terns Pharmaceuticals: A Risky Buy Ahead Of Q4 Obesity, Oncology Catalysts (NASDAQ:TERN) - Seeking Alpha
Vontobel Holding Ltd. Buys Shares of 14,000 Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Terns Pharmaceuticals CEO & Director Acquires 98% More Stock - 富途牛牛
CEO & Director of Terns Pharmaceuticals Picks Up 98% More Stock - simplywall.st
Terns pharmaceuticals CEO Burroughs buys $90k in shares - Investing.com
Terns Pharmaceuticals Presents Positive Data from Phase 1 - GlobeNewswire
Terns completes enrollment in Phase 2 obesity drug trial - Investing.com
Terns Pharmaceuticals’ SWOT analysis: promising pipeline faces competitive CML, obesity markets - Investing.com
SG Americas Securities LLC Purchases 380,489 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Analysts Set Terns Pharmaceuticals, Inc. (NASDAQ:TERN) PT at $15.63 - Defense World
Insider Buying: Andrew Gengos Acquires 15,000 Shares of Terns Pharmaceuticals Inc (TERN) - GuruFocus
Terns Pharmaceuticals Approves Directors and Accounting Firm - TipRanks
3 Penny Stocks Wall Street Sees With 243% Upside - 24/7 Wall St.
Finanzdaten der Terns Pharmaceuticals Inc-Aktie (TERN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Terns Pharmaceuticals Inc-Aktie (TERN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Gengos Andrew | Chief Financial Officer |
Jun 27 '25 |
Buy |
3.93 |
10,000 |
39,283 |
25,000 |
| Burroughs Amy L. | Chief Executive Officer |
Jun 25 '25 |
Buy |
3.87 |
23,314 |
90,230 |
47,083 |
| Gengos Andrew | Chief Financial Officer |
Jun 13 '25 |
Buy |
3.73 |
10,000 |
37,350 |
10,000 |
| Gengos Andrew | Chief Financial Officer |
Jun 16 '25 |
Buy |
3.95 |
5,000 |
19,732 |
15,000 |
| Kuriakose Emil | Chief Medical Officer |
Apr 01 '25 |
Sale |
2.49 |
952 |
2,366 |
53,317 |
| Jung Melita Sun | Chief Business Officer |
Nov 30 '24 |
Buy |
5.11 |
2,250 |
11,498 |
2,250 |
| Burroughs Amy L. | Chief Executive Officer |
Nov 30 '24 |
Buy |
5.11 |
510 |
2,606 |
19,609 |
| Kuriakose Emil | Chief Medical Officer |
Jan 02 '25 |
Sale |
5.71 |
4,481 |
25,607 |
54,269 |
| Vignola Mark J. | Chief Financial Officer |
Jan 06 '25 |
Sale |
5.80 |
9,059 |
52,500 |
74,752 |
| Vignola Mark J. | Chief Financial Officer |
Jan 02 '25 |
Sale |
5.72 |
8,129 |
46,524 |
83,811 |
4.72%
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):